Mizuho Maintains Buy on Tenet Healthcare, Raises Price Target to $100-Report released on 8th February 2024
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes has maintained a Buy rating on Tenet Healthcare (NYSE:THC) and increased the price target from $90 to $100 as of 8th February 2024.
February 09, 2024 | 3:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Ann Hynes reaffirmed a Buy rating on Tenet Healthcare and raised the price target to $100 from $90.
The increase in price target by a reputable analyst like Ann Hynes signals a strong confidence in Tenet Healthcare's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100